RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
ZDIVX
Price
$27.05
Change
-$0.12 (-0.44%)
Updated
Dec 17 closing price
Ad is loading...

RMFCX vs ZDIVX

Header iconRMFCX vs ZDIVX Comparison
Open Charts RMFCX vs ZDIVXBanner chart's image
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
Zacks Dividend Investor
Price$27.05
Change-$0.12 (-0.44%)
VolumeN/A
CapitalizationN/A
RMFCX vs ZDIVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. ZDIVX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and ZDIVX is a Hold.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. ZDIVX (129M). RMFCX pays higher dividends than ZDIVX: RMFCX (1.69) vs ZDIVX (1.33). RMFCX was incepted earlier than ZDIVX: RMFCX (23 years) vs ZDIVX (11 years). ZDIVX is a more actively managed with annual turnover of: 43.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than ZDIVX: RMFCX (250) vs ZDIVX (2500). ZDIVX annual gain was more profitable for investors over the last year : 19.18 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. ZDIVX (34.14).
RMFCXZDIVXRMFCX / ZDIVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years11 years-
Gain YTD11.42318.20363%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets104B129M80,620%
Annual Yield % from dividends1.691.33127%
Returns for 1 year12.6319.1866%
Returns for 3 years14.1614.00101%
Returns for 5 years40.3934.14118%
Returns for 10 years61.8483.5174%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc